CA-1(Grann Pharmaceuticals)

N/A

Report date: 2025/10/15 13:49:32

Base Information

Drug NameCA-1(Grann Pharmaceuticals)
Drug Alias NameCA-1
ClassificationCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsColorectal NeoplasmsAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGrann Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesGrann Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsAdenocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A